Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab
The University of Osaka · Tokyo Medical and Dental University · +8 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
741
total citations
- FWCI
- 46.50
- Percentile
- 100%
- References
- 45
Citations per year
Authors
9- NNNorihiro NishimotoCorresponding
The University of Osaka
- JHJun Hashimoto
The University of Osaka
- NMN. Miyasaka
Tokyo Medical and Dental University
- KYKazuhiko Yamamoto
The University of Tokyo
- SKShinichi Kawai
Toho University, Toho University Omori Medical Center
Topics & keywords
Topics
Keywords
- Tocilizumab
- Medicine
- Rheumatoid arthritis
- Internal medicine
- Randomized controlled trial
- Gastroenterology
- Surgery
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.